FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

385060002: Prolonged-release oral tablet (dose form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3636013018 Prolonged-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3636014012 Prolonged-release oral tablet (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3636019019 Extended-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1459238018 Prolonged-release tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1479322011 Prolonged-release tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1479322011 Prolonged-release tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2660327017 Prolonged-release tablet (qualifier value) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2660327017 Prolonged-release tablet (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3636013018 Prolonged-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3636014012 Prolonged-release oral tablet (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3636019019 Extended-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
50021051000188114 comprimé oral à libération prolongée fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
50021051000188114 comprimé oral à libération prolongée fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release oral tablet Is a A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Existential restriction modifier (core metadata concept)
Prolonged-release oral tablet Is a Conventional release oral tablet (dose form) false Inferred relationship Existential restriction modifier (core metadata concept)
Prolonged-release oral tablet Has dose form intended site (attribute) Oral true Inferred relationship Existential restriction modifier (core metadata concept)
Prolonged-release oral tablet Is a Modified-release oral tablet (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Prolonged-release oral tablet Has dose form administration method (attribute) A method of administration of a dose form by taking into the mouth and allowing to pass down the throat. true Inferred relationship Existential restriction modifier (core metadata concept)
Prolonged-release oral tablet Has dose form transformation (attribute) No transformation true Inferred relationship Existential restriction modifier (core metadata concept)
Prolonged-release oral tablet Has dose form release characteristic Prolonged-release true Inferred relationship Existential restriction modifier (core metadata concept)
Prolonged-release oral tablet Has basic dose form (attribute) A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Clarithromycin (as clarithromycin citrate) 500 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely tofacitinib (as tofacitinib citrate) 11 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely tapentadol (as tapentadol hydrochloride) 50 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely tapentadol (as tapentadol hydrochloride) 150 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Tapentadol (as tapentadol hydrochloride) 100 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely tapentadol (as tapentadol hydrochloride) 250 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely tapentadol (as tapentadol hydrochloride) 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Tamsulosin hydrochloride 400 microgram prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ranolazine 750 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Ranolazine 500 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Tacrolimus 4 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely tacrolimus 1 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Tacrolimus 750 microgram prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Nevirapine 100 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely conjugated estrogen 625 microgram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely conjugated estrogen 1.25 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely mesalazine 1 gram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely paroxetine (as paroxetine hydrochloride) 12.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely paroxetine (as paroxetine hydrochloride) 37.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely pramipexole (as pramipexole dihydrochloride) 3.15 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely pramipexole (as pramipexole dihydrochloride) 1.05 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely pramipexole (as pramipexole dihydrochloride) 2.1 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Pramipexole (as pramipexole dihydrochloride) 520 microgram prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely pramipexole (as pramipexole dihydrochloride) 260 microgram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely paracetamol 1 gram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Isosorbide mononitrate 30 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Aciclovir 1.2 g prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Nicotinic acid 375 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Finasteride 5 mg and tamsulosin hydrochloride 400 microgram prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely alfuzosin hydrochloride 10 milligram and dutasteride 500 microgram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely zolpidem tartrate 12.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely piribedil 50 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely pramipexole (as pramipexole dihydrochloride) 1.57 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Pramipexole (as pramipexole dihydrochloride) 2.62 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carvedilol phosphate 10 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carvedilol phosphate 20 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metoprolol tartrate (as metoprolol succinate) 12.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Ambroxol acefyllinate 100 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely gliclazide 60 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amoxicillin 775 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely gliclazide 60 milligram and metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely aceclofenac 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely sodium valproate 133 milligram and valproic acid 58 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely sodium valproate 200 milligram and valproic acid 87 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely lamotrigine 25 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Lamotrigine 50 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Lamotrigine 200 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely lamotrigine 300 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Lamotrigine 100 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Lamotrigine 250 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely alprazolam 1 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Alprazolam 500 microgram prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Amisulpride 100 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amisulpride 400 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amisulpride 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Prazosin (as prazosin hydrochloride) 5 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Lornoxicam 16 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely mesalazine 1.2 gram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 574.9 milligram and ciprofloxacin 425.2 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Fostemsavir (as fostemsavir trometamol) 600 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely cefaclor 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely upadacitinib 30 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely alprazolam 3 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carbamazepine 600 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carbamazepine 150 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carbamazepine 300 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier (core metadata concept)

Start Previous Page 4 of 4

This concept is not in any reference sets

Back to Start